Table 1.
Details of human endogenous retrovirus (HERV) primers and genomic regions targeted.
Target | Amplicon Size | Primers | Sequence (5′–3′) | Target Region or Reference 1 | Predicted Targets 2 |
---|---|---|---|---|---|
HERV-K Gag | 113 bp | Fwd | TTCCCGAGTACGTCTACAGTGA | [19] | 1 |
Rev | GGTGTTTCTCATCAGGTGGAAT | ||||
HERV-K Np9 | 113 bp | Fwd | GTTAGTCTACAGGTGTATCCA | GenBank Y17832.2 8836–8948 |
1 |
Rev | CTGTCTCTTTTCCCTACATTTCC | ||||
HERV-W Gag | 81 bp | Fwd | TCAGGTCAACAATAGGATGACAACA | [21] | 1 |
Rev | CAATGAGGGTCTACACTGGGAACT | ||||
HERV-E Pol | 98 bp | Fwd | CTCTACACAGTTAGGCTCG | Chr13 40,349,095–40,349,192 |
1 |
Rev | GTGAAAATCCCCGCATAACC | ||||
HERV_E Env | 168 bp | Fwd | ATTTGATGCTTGTGCAGCCA | [22] | 2 3 |
Rev | TTCTTTTTCCAAGTAGCCCAAAT | ||||
HERV_H Pol | 118 bp | Fwd | GCCAAACACATATACTCTCC | Chr8 8,066,673–8,066,790 |
1 |
Rev | GAAGAGTGACTGGGATGAAG |
1 Chromosome position based on Human Genome Sequence version hg18. 2 Number of amplified targets predicted within the genome by MFEPrimer analysis. 3 Two DNA targets are on chr17 and chr19, which are both 168 base pairs in length and share 95% nucleotide sequence identity.